Threat to cefixime treatment for gonorrhea
- PMID: 17953118
- PMCID: PMC2828067
- DOI: 10.3201/eid1308.060948
Threat to cefixime treatment for gonorrhea
Similar articles
-
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.Emerg Infect Dis. 2016 Jun;22(6):1139-41. doi: 10.3201/eid2206.152091. Emerg Infect Dis. 2016. PMID: 27191699 Free PMC article. No abstract available.
-
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.Sex Transm Infect. 2010 Nov;86(6):454-60. doi: 10.1136/sti.2010.045377. Sex Transm Infect. 2010. PMID: 20940159
-
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.Euro Surveill. 2010 Nov 25;15(47):19721. doi: 10.2807/ese.15.47.19721-en. Euro Surveill. 2010. PMID: 21144442
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
-
Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76. doi: 10.1586/eri.11.103. Expert Rev Anti Infect Ther. 2011. PMID: 21973299 Review.
Cited by
-
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?Antimicrob Agents Chemother. 2012 May;56(5):2739-42. doi: 10.1128/AAC.00036-12. Epub 2012 Feb 21. Antimicrob Agents Chemother. 2012. PMID: 22354296 Free PMC article.
-
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.BMC Infect Dis. 2013 Jan 25;13:40. doi: 10.1186/1471-2334-13-40. BMC Infect Dis. 2013. PMID: 23351067 Free PMC article.
-
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. Clin Microbiol Rev. 2014. PMID: 24982323 Free PMC article. Review.
-
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.Ann Intern Med. 2013 Mar 5;158(5 Pt 1):321-8. doi: 10.7326/0003-4819-158-5-201303050-00004. Ann Intern Med. 2013. PMID: 23460055 Free PMC article.
-
Expedited partner therapy for sexually transmitted infections.Curr Opin Obstet Gynecol. 2012 Oct;24(5):299-304. doi: 10.1097/GCO.0b013e3283577e9d. Curr Opin Obstet Gynecol. 2012. PMID: 22907483 Free PMC article. Review.
References
-
- Ito M, Degcuhi T, Mizutani KS, Yasuda M, Yokoi S, Ito SI, et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother. 2005;49:137–43. 10.1128/AAC.49.1.137-143.2005 - DOI - PMC - PubMed
-
- National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 6th ed. (M7-A6). Wayne (PA): the Committee.
-
- Japanese Society for Sexually Transmitted Diseases. Guidelines for the diagnosis and treatment of sexually transmitted diseases 2004. Jpn J Sex Transm Dis. 2004;15(Suppl 1):8–13.
-
- Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother. 2002;46:3744–9. 10.1128/AAC.46.12.3744-3749.2002 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical